A preliminary study showed prolonged viral suppression is feasible with anti-HIV-1 antibody therapy.
18 Apr, 2022 | 10:06h | UTCProlonged viral suppression with anti-HIV-1 antibody therapy – Nature
Commentary on Twitter
Still in disbelief but our paper is now out in @nature!
We show that immunotherapy with two broadly neutralizing anti-HIV-1 antibodies maintains virologic suppression for several months in people living with HIV in the absence of anti-retroviral therapy.https://t.co/eVem5yDE0C
— Christian Gaebler (@c_gaebler) April 14, 2022